The HIV drugs included Biktarvy, Complera, Descovy, Genvoya, Odefsey and Stribild.
HIV drug kickbacks: Gilead Sciences to pay USD 202 million to settle lawsuit
Advertisement
New York: Gilead Sciences has agreed to pay USD 202 million to settle a whistleblower lawsuit that accused the company of engaging in civil fraud by providing illegal kickbacks to doctors in exchange for prescribing its HIV medications.
The settlement, announced by U.S. Attorney Jay Clayton in Manhattan, resolved allegations that Gilead violated the federal False Claims Act by defrauding Medicare, Medicaid, and other programs into paying for drugs prescribed by doctors who spoke at and attended Gilead's promotional speaker programs.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.